Lumibird SA (EPA:LBIRD)
23.60
0.00 (0.00%)
Feb 2, 2026, 11:42 AM CET
Lumibird Market Cap
Lumibird has a market cap or net worth of €519.71 million as of February 2, 2026. Its market cap has increased by 183.26% in one year.
Market Cap
519.71M
Enterprise Value
614.17M
Revenue
219.10M
Ranking
n/a
PE Ratio
48.45
Stock Price
€23.60
Market Cap Chart
Since July 25, 2018, Lumibird's market cap has increased from 230.33M to 519.71M, an increase of 125.64%. That is a compound annual growth rate of 11.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 519.71M | 11.32% |
| Dec 31, 2025 | 466.86M | 126.73% |
| Dec 31, 2024 | 205.91M | -23.62% |
| Dec 29, 2023 | 269.59M | -27.13% |
| Dec 30, 2022 | 369.94M | -30.68% |
| Dec 31, 2021 | 533.70M | 70.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 119.46B |
| Sanofi | 95.74B |
| Sartorius Stedim Biotech | 18.32B |
| Eurofins Scientific SE | 12.03B |
| Inventiva | 955.16M |
| Nanobiotix | 844.85M |
| MedinCell | 746.80M |
| Valneva SE | 674.24M |